VIRALYTICS LIMITED
Entity Overview
VIRALYTICS LIMITED was an Australian Public Company registered in New South Wales. The ABN was cancelled on the 9 February 2024 and is not currently registered for GST. It was registered with ASIC on the 14 August 1986 as an Australian public company, Limited by Shares. It has previously been known as PSIRON LTD, MEDICAL INNOVATIONS LIMITED.
Viralytics Limited is an Australian biotechnology company focused on the research, development, and commercialisation of oncolytic immunotherapy treatments for various cancers. Its core product candidate is CAVATAK, a proprietary formulation of a common cold virus designed to preferentially infect, lyse, and destroy cancer cells while stimulating an anti-tumour immune response. The company develops targeted treatments aimed at addressing difficult-to-treat malignancies such as melanoma, prostate, lung, and bladder cancers.
We weren't able to find any other public information on this company.
Australian Business Register (ABR) Last updated: 13 February 2024
Australian Securities & Investments Commission (ASIC) Registered since 14 August 1986 (40y 2m 23d)
| Name history | From | To |
|---|---|---|
| VIRALYTICS LIMITED | 21 January 2024 | (current) |
| PSIRON LTD | 21 January 2024 | 21 January 2024 |
| MEDICAL INNOVATIONS LIMITED | 14 August 1986 | 21 January 2024 |
Name history
Related entities Entities sharing key name terms
| Entity ID | Name | Status |
|---|